Olga V. Samodova

Olga V. Samodova

Auto-generated profile, based on publicly available information

Olga V. Samodova

Northern State Medical University

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Social Aspects of Population Health
Verified
Journal Article
Closed access
IPI.M. Pastbina
I.M. Pastbina
EKE.A. Krieger
E.A. Krieger
OSO.V. Samodova
O.V. Samodova
????: ????? ?????????? ??? ??????? ??????????? ???????????????? ?????? ? ???????, ???????? ?????, ?????????? ?? ??????????? ?????? ???????????? ?????? ???????? ???????.

7 October 2018 in Journal Infectology
Verified
Journal Article
Open access
PDF file
IBI. V. Babachenko
I. V. Babachenko
OSO. V. Samodova
O. V. Samodova
VAVladimir Алексеевич Anokhin
Vladimir Алексеевич Anokhin
EME. V. Mikhaylova
E. V. Mikhaylova
ABA. V. Bogdanova
A. V. Bogdanova
SGS. G. Grigor’ev
S. G. Grigor’ev
Целью настоящего исследования являлось изучение клинико-эпидемиологических особенностей респираторно-синцитиальной вирусной инфекции (РСВИ) у госпитализированных по поводу заболеваний нижних дыхательных путей детей первого года жизни в различных регионах Российской Федерации (РФ) в эпидемический сезон 2015–2016 гг. Материалы и методы: в оригинальном исследовании представлены данные многоцентрового наблюдательного исследования, проведенного на базе детских стационаров Санкт-Петербурга, Архангельска, Казани, Саратова. Этиологию острых респираторных вирусных инфекций подтверждали исследованием мазков с задней стенки глотки методом полимеразной цепной реакции. Всего обследован 991 ребенок первого года жизни с поражением нижних дыхательных путей. Результаты: в этиологической структуре обследованных детей в сезон 2015–2016 гг. РСВИ составляла от 14% до 46,2%. РСВИ доминировала в центрах Санкт-Петербурга (38,3%), Архангельска (36,2%) и Казани (42,5%). РСВИ достоверно чаще приводит к развитию бронхиолита (29,4%), чем риновирусная инфекция и парагрипп (16,3% и 10,0% соответственно) (р<0,01), а также пневмонии – 23,5% против 20,6% и 20,0% при риновирусной инфекции и парагриппе. Пациенты с РСВИ чаще переносят тяжелые формы заболевания, требуют кислородной поддержки (13,8%) и лечения в условиях отделения реанимации и интенсивной терапии (15,9%). Сезонные пики госпитализации, обусловленной РСВИ, во всех центрах регистрировали в декабре – апреле 2015 и 2016 гг. Установлены региональные различия в помесячной интенсивности госпитализации детей с ОРВИ. Таким образом, высокая распространенность РСВИ среди детей первого года жизни, особенно с тяжелыми и осложненными формами поражения нижних дыхательных путей, с необходимостью реанимационного пособия, представляет социально-значимую проблему, что требует проведения мониторинга для эффективной профилактики у детей групп риска.

15 March 2023 in Infectious Diseases
Verified
Journal Article
Open access
EKEkaterina Krieger
Ekaterina Krieger
Ekaterina SharashovaEkaterina Sharashova
Ekaterina Sharashova
AKAlexander V. Kudryavtsev
Alexander V. Kudryavtsev
OSOlga Samodova
Olga Samodova
AKAnna Kontsevaya
Anna Kontsevaya
VPVitaly Postoev
Vitaly Postoev
The published estimates of SARS-CoV-2 seroprevalence in Russia are few. The study aimed to assess the SARS-CoV-2 seroprevalence in Arkhangelsk (Northwest Russia), in a year after the start of the p...

15 September 2022 in Epidemiology and Vaccinal Prevention
Verified
Journal Article
Open access
PDF file
OSO. V. Samodova
O. V. Samodova
EKE. A. Krieger
E. A. Krieger
NRN. L. Rogushina
N. L. Rogushina
Relevance. During the ongoing pandemic of a new coronavirus infection (COVID-19), assessment of humoral immunity to vaccine preventable diseases in healthcare workers is crucial to estimate the risk of healthcare-associated infections. Aim. To assess the humoral immunity to vaccine-preventable diseases: whooping cough, influenza A, viral hepatitis A and B, new coronavirus infection (COVID-19), in healthcare professionals working with infectious patients. Materials and methods. We conducted a cross-sectional study enrolling 252 healthcare workers, which included a survey and assessment of immunoglobulins G to Bordetella pertussis, influenza A virus, hepatitis A virus, HBsAg and HBcAg of hepatitis B virus, and SARS- COV-2 by enzyme immunoassay. Results. The proportion of healthcare workers seronegative to pertussis was 46.8%, to influenza – 31.4%, to hepatitis A – 52.4%, to hepatitis B – 27.5%, to the SARS-CoV-2 virus – 29.8%. In 8.0% of cases the level of antibodies to Bordetella pertussis indicated a recent infection. The largest proportion of seronegative to pertussis (55.2%) was among individuals younger than 30 years. More than 80% of healthcare workers were vaccinated against seasonal influenza A during the previous year, 67.6% of them were seropositive. More than half (51.8%) of vaccinated but seronegative to influenza A health workers were older than 50 years. The odds of being seropositive to influenza A decreased with age, while the odds of being seropositive for viral hepatitis A increased with age. Vaccination against viral hepatitis B was received by 86.9% of people, 78.5% of them were seropositive to HBsAg, the remaining 21.5% needed revaccination. The proportion of healthcare workers seropositive for the SARS-CoV-2 virus was 57.5%, equivocal results were obtained in 12.7% of cases. The proportion of seronegative among those who had previously had COVID-19 was 40%, while among those who were vaccinated – 17.4%. Conclusion. The study showed a complex assessment of humoral immunity to the most common vaccine-preventable diseases: pertussis, influenza A, viral hepatitis А, B and novel coronavirus infection (COVID-19) in healthcare workers during the ongoing pandemic and allowed to make the following conclusions: 1. The proportion of healthcare workers susceptible to pertussis was 46.8% that required regular vaccination/revaccination of the seronegative healthcare workers to reduce the risk of infections healthcare-associated infections. 2. The proportion of healthcare workers vaccinated against influenza was 80% and exceeded the proportion of seropositive – 68.7%. 3. The proportion of healthcare workers seronegative to viral hepatitis B was 27.5%, to viral hepatitis A – 52.4%. 4. The COVID-19 seroprevalence among healthcare workers was 57.5%, regardless of whether it was obtained naturally or via vaccination. The proportion of seronegative healthcare workers among those having COVID-19 was 40%, among vaccinated – 17.4%, which confirms the necessity of vaccination / revaccination either after the infection or after the vaccination.

1 January 2019 in International Journal of Circumpolar Health
Verified
Journal Article
Open access
TBTatiana Balaeva
Tatiana Balaeva
AGAndrej M Grjibovski
Andrej M Grjibovski
OSOlga Samodova
Olga Samodova
ASAnatoly Sannikov
Anatoly Sannikov
EKElise Klouman
Elise Klouman
Hepatitis C, caused by the hepatitis C virus (HCV), is a major public health issue in Russia. The aim of our study was to assess the seroprevalence of markers of HCV exposure and factors associated with HCV seropositivity among the general population aged 18–39 years in the city of Arkhangelsk, Northwest Russia. A social research agency applied a quota sampling method to recruit study participants using cell phone numbers. All participants (n = 1243) completed a self-administered questionnaire and provided a blood sample. Sixty-five participants (5.2%, 95% confidence interval [CI] 4.9–5.5) tested positive for HCV IgM+G antibodies, and of these, 55 (84.6%) did not know that they were exposed to HCV. In multivariable logistic regression analysis, HCV seropositivity was significantly associated with older age, a history of injecting drug use, and having ever received a blood transfusion. To reach the goal of the World Health Organisation’s Global Health Sector Strategy on Viral Hepatitis, regional preventive programmes should include measures to reduce injecting drug use as well as scaling up harm-reduction and treatment programs for drug addicts.

9 October 2019 in Journal Infectology
Verified
Journal Article
Open access
PDF file
OSO. V. Samodova
O. V. Samodova
EKE. A. Krieger
E. A. Krieger
LTL. V. Titova
L. V. Titova
OLO. Yu. Leonteva
O. Yu. Leonteva
Generalized forms of meningococcal infection are characterized by high risk of complication and fatal outcomes. In Russian Federation, 2016, meningococcal infection was the second most common cause of pediatric deaths (25%) due to infectious diseases after community associated-pneumonia. Mandatory vaccination against meninococcal infection is not regulated, and immunization coverage according to epidemic indications is insufficient. During first 6–8 hours of illness clinical signs of this infection may be non-specific, because of that it is difficult to make correct diagnosis at outpatient department. Aim of the study was to analyze mistakes of diagnostics of meningococcal infection and to assess factors influencing the disease outcome. Material and methods. Retrospective cohort study was performed including 113 pediatric cases of generalized meningococcal infection occurred in Arkhangelsk region (46 cases with fatal outcome and 67 patients, who recovered). Factors influencing the outcome were recognized using Cox regression. Results. Median age of patients was 11 months. Clinical forms were meningitis (13,3%), meningococcemia (40,7%), mixed form (46%). The diagnosis of meningococcal infection was made at outpatient department in 36,9% of cases. The main causes of diagnostic mistakes were the lack of experience among primary care physicians and non-specificic symptoms during the first hours of the disease. Age younger 2 years, septic shock and time between onset of the diseases and admission to the hospital were associated with fatal outcome. Conclusion. To manage meningococcal disease we need to have good compliance with clinical guidelines for outpatient departments and hospitals; to optimize medical students education for prevention of diagnostic mistakes. Vaccination is the most effective method of prevention of deaths associated with meningococcal infection.